Items Tagged ‘sarcoma’
May 12, 2017
Mayo Clinic launches first-in-world mate-pair sequencing test
By Sharon Rosen 
Many families are on a medical journey to find answers to a loved one’s undiagnosed disease. This can be painfully frustrating, expensive, and time-consuming. Now, a new test from Mayo Clinic hopes to help patients who may be at a diagnostic “dead end” with other genetic testing. The first-in-the-world mate-pair sequencing test identifies chromosome alterations […]
Tags: #chromosome, #congenital, #developmental, #DNA sequencing tests, #Dr. George Vasmatizis, #Dr. Nicole Lynn Hoppman, #genomic tests, #laboratory tests, #leukemia, cancer, center for individualized medicine, DNA
January 19, 2017
Researchers identify new drug target for gastrointestinal stromal tumors
By Sharon Rosen
Article by Colette Gallagher, Public Affairs Tamas Ordog, M.D., director of the Epigenomics Program at the Mayo Clinic Center for Individualized Medicine, and Jason Sicklick, M.D., of UC San Diego Health, identified a new drug target for gastrointestinal stromal tumors. Gastrointestinal stromal tumors (GIST) are the most common sarcoma with an estimated annual incidence of […]
Tags: #Dr. Tamas Ordog, #drug target, #Gastrointestinal stromal tumors, #GI cancer, #GIST, center for individualized medicine, mayo clinic, medical research, sarcoma
November 23, 2016
Mayo Clinic investigators pinpoint cause, possible treatment for rare form of sarcoma
More than 12,000 Americans will be diagnosed with some type of soft tissue sarcoma this year. Sarcoma can be very difficult to treat, particularly when it has metastasized and spread to other parts of the body. Nearly 5,000 people will die from the disease this year, according to the American Cancer Society. New research from […]
Tags: #Dr. Aaron Mansfield, #inflammatory myofibroblastic tumors, #PrecisionMedicine, center for individualized medicine, Dr. George Vasmatzis, mayo clinic, sarcoma
February 18, 2014
New Insights Into Sarcoma Genomic Basis Revealed in Mayo Clinic Research
Whole Genome Analyses of a Well-Differentiated Liposarcoma Reveals Novel SYT1 and DDR2 Rearrangements Source: PLOS ONE Liposarcoma is the most common soft tissue sarcoma, but little is known about the genomic basis of this disease. Given the low cell content of this tumor type, we utilized flow cytometry to isolate the diploid normal and […]
Tags: center for individualized medicine, DNA, DNA Sequencing, genetic, Genetic Sequencing, Genomic, genomics, individualized medicine, Liposarcoma, mayo clinic, personalized care, personalized medicine